SAN DIEGO, CA - March 12, 2025 ( NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY) today released the following note authored by its CEO, Jim Joyce.

After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...

The National Institutes of Health, which falls under the jurisdiction of HHS, has terminated grants for research into vaccine hesitancy, according to the Washington Post, even though the Texas measles ...

Today, the Regina Leader-Post and Saskatoon StarPhoenix are reflecting on COVID-19 through the unique lens of the photojournalists who helped document the pandemic.

Across the UK, events have been held to commemorate the fifth anniversary of the pandemic’s onset, paying tribute to the ...

Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 VERITAC-2 clinical trial (NCT05654623) evaluating vepdegestrant monotherapy versus ...

Transthyretin Amyloid Cardiomyopathy Treatment Market is estimated to be valued at US$ 1.69 Bn in 2023, and is expected to exhibit a CAGR of 31.1% by 2030. Mr. Shah Coherent Market Insights Pvt. Ltd.

BioSpace remembers COVID-19 five years after the pandemic was declared, Novo Nordisk’s CagriSema again misses expectations as the company joins a lawsuit filed by drug compounders against the FDA, ...

At five years since COVID-19 began sweeping through Fond du Lac, here are some stories, from lost loved ones to long-term ...

It was exactly this week, in 2020, when COVID officially entered the mass consciousness: The NBA suddenly canceled its season ...

Discover the importance of adult vaccination in India, the barriers faced, and the urgent need for prioritization.